HOME | DEUTSCH | CONTACT | SITEMAP | IMPRINT
ABOUT | NEWS | PRODUCTS | TECHNOLOGY | INVESTOR RELATIONS | CAREER
Postal address:
Fabeckstr. 30 14195 Berlin Germany
Phone:
+ 49 (0)30 - 84 17 88 - 0
Fax:
+ 49 (0)30 - 84 17 88 - 50
E-mail:
info@mologen.com
ContactInvestor Relations:
Mr. Joerg Petrass investor@mologen.com
ContactResearch & Development:
Dr. Matthias Schroff research@mologen.com
ContactBusiness Development:
Ms. Arlett Killat bizdev@mologen.com
Contact - INDIAONCO Life Sciences:
Ashish Agarwal ashish@onco.in
MOLOGEN AG receives approval for clinical study with cell-based gene therapy against renal cancer
press release
ad-hoc announcement
MOLOGEN AG starts phase 2 clinical study with DNA-based cancer medicine MGN1703 against colorectal cancer
more
To subscribe to our Newsletter please
click here
More information about our products
CELL-BASED GENE THERAPY
CANCER THERAPY WITH dSLIM
More information about our technologies
MIDGE
MIDGE-Th1
dSLIM
TOP OF PAGE | HOME | IMPRINT | DISCLAIMER
GENE
THERAPY